133 related articles for article (PubMed ID: 18224398)
1. Preclinical studies of molecular-targeting diagnostic and therapeutic strategies against breast cancer.
Fujii T; Yokoyama G; Takahashi H; Namoto R; Nakagawa S; Toh U; Kage M; Shirouzu K; Kuwano M
Breast Cancer; 2008; 15(1):73-8. PubMed ID: 18224398
[TBL] [Abstract][Full Text] [Related]
2. Preclinical and clinical studies of novel breast cancer drugs targeting molecules involved in protein kinase C signaling, the putative metastasis-suppressor gene Cap43 and the Y-box binding protein-1.
Fujii T; Yokoyama G; Takahashi H; Toh U; Kage M; Ono M; Shirouzu K; Kuwano M
Curr Med Chem; 2008; 15(6):528-37. PubMed ID: 18336267
[TBL] [Abstract][Full Text] [Related]
3. 17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells.
Fotovati A; Fujii T; Yamaguchi M; Kage M; Shirouzu K; Oie S; Basaki Y; Ono M; Yamana H; Kuwano M
Clin Cancer Res; 2006 May; 12(10):3010-8. PubMed ID: 16707596
[TBL] [Abstract][Full Text] [Related]
4. Cell growth inhibition by all-trans retinoic acid in SKBR-3 breast cancer cells: involvement of protein kinase Calpha and extracellular signal-regulated kinase mitogen-activated protein kinase.
Nakagawa S; Fujii T; Yokoyama G; Kazanietz MG; Yamana H; Shirouzu K
Mol Carcinog; 2003 Nov; 38(3):106-16. PubMed ID: 14587095
[TBL] [Abstract][Full Text] [Related]
5. Identification of sites subjected to serine/threonine phosphorylation by SGK1 affecting N-myc downstream-regulated gene 1 (NDRG1)/Cap43-dependent suppression of angiogenic CXC chemokine expression in human pancreatic cancer cells.
Murakami Y; Hosoi F; Izumi H; Maruyama Y; Ureshino H; Watari K; Kohno K; Kuwano M; Ono M
Biochem Biophys Res Commun; 2010 May; 396(2):376-81. PubMed ID: 20416281
[TBL] [Abstract][Full Text] [Related]
6. Antineoplaston induces G(1) arrest by PKCalpha and MAPK pathway in SKBR-3 breast cancer cells.
Fujii T; Nakamura AM; Yokoyama G; Yamaguchi M; Tayama K; Miwa K; Toh U; Kawamura D; Shirouzu K; Yamana H; Kuwano M; Tsuda H
Oncol Rep; 2005 Aug; 14(2):489-94. PubMed ID: 16012735
[TBL] [Abstract][Full Text] [Related]
7. Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.
Fujii T; Kawahara A; Basaki Y; Hattori S; Nakashima K; Nakano K; Shirouzu K; Kohno K; Yanagawa T; Yamana H; Nishio K; Ono M; Kuwano M; Kage M
Cancer Res; 2008 Mar; 68(5):1504-12. PubMed ID: 18316615
[TBL] [Abstract][Full Text] [Related]
8. NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer.
Azuma K; Kawahara A; Hattori S; Taira T; Tsurutani J; Watari K; Shibata T; Murakami Y; Takamori S; Ono M; Izumi H; Kage M; Yanagawa T; Nakagawa K; Hoshino T; Kuwano M
J Thorac Oncol; 2012 May; 7(5):779-89. PubMed ID: 22481237
[TBL] [Abstract][Full Text] [Related]
9. N-myc downstream regulated gene1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0/G1 phase.
Akiba J; Murakami Y; Noda M; Watari K; Ogasawara S; Yoshida T; Kawahara A; Sanada S; Yasumoto M; Yamaguchi R; Kage M; Kuwano M; Ono M; Yano H
Cancer Lett; 2011 Nov; 310(1):25-34. PubMed ID: 21775055
[TBL] [Abstract][Full Text] [Related]
10. N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin.
Song Y; Oda Y; Hori M; Kuroiwa K; Ono M; Hosoi F; Basaki Y; Tokunaga S; Kuwano M; Naito S; Tsuneyoshi M
Hum Pathol; 2010 Feb; 41(2):214-22. PubMed ID: 19800102
[TBL] [Abstract][Full Text] [Related]
11. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
Yu YN; Yip GW; Tan PH; Thike AA; Matsumoto K; Tsujimoto M; Bay BH
Int J Oncol; 2010 Aug; 37(2):483-92. PubMed ID: 20596676
[TBL] [Abstract][Full Text] [Related]
12. The expression of activated Y-box binding protein-1 serine 102 mediates trastuzumab resistance in breast cancer cells by increasing CD44+ cells.
Dhillon J; Astanehe A; Lee C; Fotovati A; Hu K; Dunn SE
Oncogene; 2010 Nov; 29(47):6294-300. PubMed ID: 20802512
[TBL] [Abstract][Full Text] [Related]
13. N-myc downstream regulated gene 1/Cap43 suppresses tumor growth and angiogenesis of pancreatic cancer through attenuation of inhibitor of kappaB kinase beta expression.
Hosoi F; Izumi H; Kawahara A; Murakami Y; Kinoshita H; Kage M; Nishio K; Kohno K; Kuwano M; Ono M
Cancer Res; 2009 Jun; 69(12):4983-91. PubMed ID: 19491262
[TBL] [Abstract][Full Text] [Related]
14. Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells.
Basaki Y; Hosoi F; Oda Y; Fotovati A; Maruyama Y; Oie S; Ono M; Izumi H; Kohno K; Sakai K; Shimoyama T; Nishio K; Kuwano M
Oncogene; 2007 Apr; 26(19):2736-46. PubMed ID: 17072343
[TBL] [Abstract][Full Text] [Related]
15. Identification of 2,4-dihydroxy-5-pyrimidinyl imidothiocarbomate as a novel inhibitor to Y box binding protein-1 (YB-1) and its therapeutic actions against breast cancer.
Gunasekaran VP; Nishi K; Sivakumar D; Sivaraman T; Mathan G
Eur J Pharm Sci; 2018 Apr; 116():2-14. PubMed ID: 28916481
[TBL] [Abstract][Full Text] [Related]
16. N-myc downstream-regulated gene 1/Cap43 expression promotes cell differentiation of human osteosarcoma cells.
Matsugaki T; Zenmyo M; Hiraoka K; Fukushima N; Shoda T; Komiya S; Ono M; Kuwano M; Nagata K
Oncol Rep; 2010 Sep; 24(3):721-5. PubMed ID: 20664979
[TBL] [Abstract][Full Text] [Related]
17. MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition.
Astanehe A; Finkbeiner MR; Krzywinski M; Fotovati A; Dhillon J; Berquin IM; Mills GB; Marra MA; Dunn SE
Oncogene; 2012 Oct; 31(41):4434-46. PubMed ID: 22249268
[TBL] [Abstract][Full Text] [Related]
18. Y-box binding protein-1 (YB-1) promotes cell cycle progression through CDC6-dependent pathway in human cancer cells.
Basaki Y; Taguchi K; Izumi H; Murakami Y; Kubo T; Hosoi F; Watari K; Nakano K; Kawaguchi H; Ohno S; Kohno K; Ono M; Kuwano M
Eur J Cancer; 2010 Mar; 46(5):954-65. PubMed ID: 20079629
[TBL] [Abstract][Full Text] [Related]
19. Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells.
Kruger JS; Reddy KB
Mol Cancer Res; 2003 Sep; 1(11):801-9. PubMed ID: 14517342
[TBL] [Abstract][Full Text] [Related]
20. N-myc downstream-regulated gene 1 (NDRG1) a differentiation marker of human breast cancer.
Fotovati A; Abu-Ali S; Kage M; Shirouzu K; Yamana H; Kuwano M
Pathol Oncol Res; 2011 Sep; 17(3):525-33. PubMed ID: 21221878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
